• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Trypanosoma cruzi: biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle.

作者信息

Engel J C, Doyle P S, Dvorak J A

出版信息

J Protozool. 1985 Feb;32(1):80-3. doi: 10.1111/j.1550-7408.1985.tb03017.x.

DOI:10.1111/j.1550-7408.1985.tb03017.x
PMID:3921699
Abstract

The complete intracellular cycle of five cloned stocks of Trypanosoma cruzi was quantified. Marked but stable interclonal differences were found in the length of the pre-replicative lag period (18.2-34.2 h), amastigote doubling time (8.6-21.5 h), and duration of the complete intracellular cycle (96-215 h). Strong correlations were demonstrated between these characteristics as well as to the growth rate of the epimastigote stage of the same clones grown in liquid medium. These data demonstrate that the marked heterogeneity of the natural population of T. cruzi extends to the intracellular cycle of the parasite and has important implications for our understanding of Chagas' disease.

摘要

相似文献

1
Trypanosoma cruzi: biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle.
J Protozool. 1985 Feb;32(1):80-3. doi: 10.1111/j.1550-7408.1985.tb03017.x.
2
Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium.克氏锥虫:来自两名慢性恰加斯病患者的19个克隆的生物学特性。I. 液体培养基中的生长动力学
J Protozool. 1982 Nov;29(4):555-60. doi: 10.1111/j.1550-7408.1982.tb01334.x.
3
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.克氏锥虫的天然异质性:生物学及医学意义
J Cell Biochem. 1984;24(4):357-71. doi: 10.1002/jcb.240240406.
4
Diversity of Trypanosoma cruzi stocks and clones derived from Chagas disease patients: I--Behavioral characterization in vitro.源自恰加斯病患者的克氏锥虫株系和克隆的多样性:I——体外行为特征
Rev Soc Bras Med Trop. 1997 May-Jun;30(3):187-92. doi: 10.1590/s0037-86821997000300003.
5
Trypanosoma cruzi: isolation of cloned strains and characterization of their infectivity.克氏锥虫:克隆菌株的分离及其感染性的特征分析
J Parasitol. 1985 Aug;71(4):397-402.
6
Virulence and pathogenicity associated with diversity of Trypanosoma cruzi stocks and clones derived from Chagas' disease patients.与源自恰加斯病患者的克氏锥虫株系和克隆的多样性相关的毒力和致病性。
Am J Trop Med Hyg. 1996 Sep;55(3):304-10. doi: 10.4269/ajtmh.1996.55.304.
7
Introducing a Gene Knockout Directly Into the Amastigote Stage of Trypanosoma cruzi Using the CRISPR/Cas9 System.利用CRISPR/Cas9系统将基因敲除直接引入克氏锥虫的无鞭毛体阶段。
J Vis Exp. 2019 Jul 31(149). doi: 10.3791/59962.
8
[Update on the treatment of Chagas' disease].[恰加斯病治疗的最新进展]
Rev Med Chil. 2011 Feb;139(2):247-57. Epub 2011 Jul 11.
9
Trypanosoma cruzi: cell biological behavior of epimastigote and amastigote forms in axenic culture.克氏锥虫:无共栖培养中前鞭毛体和无鞭毛体形式的细胞生物学行为
J Protozool. 1988 Nov;35(4):513-8. doi: 10.1111/j.1550-7408.1988.tb04140.x.
10
Modulation of host central carbon metabolism and in situ glucose uptake by intracellular Trypanosoma cruzi amastigotes.细胞内克氏锥虫无鞭毛体对宿主中心碳代谢和原位葡萄糖摄取的调节作用。
PLoS Pathog. 2017 Nov 27;13(11):e1006747. doi: 10.1371/journal.ppat.1006747. eCollection 2017 Nov.

引用本文的文献

1
Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts.感染部位 T 细胞的延迟激活有助于在无免疫和免疫宿主中建立克氏锥虫。
mSphere. 2023 Feb 21;8(1):e0060122. doi: 10.1128/msphere.00601-22. Epub 2023 Jan 25.
2
TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling.三磷酸对甲苯磺酸盐,一种单一的、口服的杀血吸虫前药:体内疗效、处置和代谢特征。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):571-586. doi: 10.1016/j.ijpddr.2018.10.004. Epub 2018 Nov 20.
3
4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.
基于4-氨基吡啶基的CYP51抑制剂作为抗克氏锥虫药物先导物,具有改善的药代动力学特征和体内效力。
J Med Chem. 2014 Aug 28;57(16):6989-7005. doi: 10.1021/jm500448u. Epub 2014 Aug 19.
4
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.硝基杂环化合物对克氏锥虫的疗效比CYP51抑制剂更好:对恰加斯病药物研发的启示。
Sci Rep. 2014 Apr 16;4:4703. doi: 10.1038/srep04703.
5
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.针对克氏锥虫 CYP51 的不同抑制剂化学型。
PLoS Negl Trop Dis. 2012;6(7):e1736. doi: 10.1371/journal.pntd.0001736. Epub 2012 Jul 31.
6
The Trypanosoma cruzi protease cruzain mediates immune evasion.克氏锥虫蛋白酶 cruzain 介导免疫逃避。
PLoS Pathog. 2011 Sep;7(9):e1002139. doi: 10.1371/journal.ppat.1002139. Epub 2011 Sep 1.
7
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.基于图像的高通量药物筛选,针对克氏锥虫的细胞内阶段,克氏锥虫是恰加斯病的病原体。
Antimicrob Agents Chemother. 2010 Aug;54(8):3326-34. doi: 10.1128/AAC.01777-09. Epub 2010 Jun 14.
8
Why does GM1 induce a potent beneficial response to experimental Chagas disease?为什么GM1对实验性恰加斯病会引发强大的有益反应?
HFSP J. 2009;3(2):142-51. doi: 10.2976/1.3067922. Epub 2009 Jan 21.
9
Two approaches to discovering and developing new drugs for Chagas disease.两种发现和开发治疗恰加斯病新药的方法。
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1(0 1):263-9. doi: 10.1590/s0074-02762009000900034.
10
Enucleated L929 cells support invasion, differentiation, and multiplication of Trypanosoma cruzi parasites.去核的L929细胞支持克氏锥虫寄生虫的侵袭、分化和增殖。
Infect Immun. 2007 Aug;75(8):3700-6. doi: 10.1128/IAI.00194-07. Epub 2007 May 14.